Budoff, M., Muhlestein, B., Le, V., May, H., Roy, S., & . (2018). Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study. Clinical Cardiology. https://doi.org/10.1002/clc.22856 (Original work published 2018)